Clinical Trial

Combined Immunosuppression for Pediatric Crohn's Disease

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a randomized controlled trial to compare the efficacy and safety of infliximab and immunosuppressives therapy alone or in combination for pediatric Crohn's disease.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-09-05; most recent amendment 2026-03-17.
Status change: Not Yet Recruiting → Recruiting 2022-10-11
Trial Details
NCT Number NCT05043870
Lead Sponsor Children's Hospital of Fudan University
Conditions Crohn Disease, Infliximab, Immunosuppression, Children, Only
Enrollment 128 participants
Start Date 2022-10-10
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-19